1. A favorable inductive remission rate for decitabine combined with chemotherapy as a first course in <60‐year‐old acute myeloid leukemia patients with myelodysplasia syndrome features. (19th July 2019) Authors: Liu, Fengqi; Wang, Hehua; Liu, Junru; Zhou, Zhenhai; Zheng, Dong; Huang, Beihui; Su, Chang; Zou, Waiyi; Xu, Duorong; Tong, Xiuzhen; Li, Juan Journal: Cancer medicine Issue: Volume 8:Number 11(2019:Sep.) Page Start: 5108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients. Issue 1 (28th December 2017) Authors: Zhang, Xuanye; Rao, Huilan; Xu, Xiaolu; Li, Zhihua; Liao, Bing; Wu, Hongmei; Li, Mei; Tong, Xiuzhen; Li, Juan; Cai, Qingqing Journal: Cancer science Issue: Volume 109:Issue 1(2018) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and side-effects of decitabine in treatment of atypical chronic myeloid leukemia. Issue 6 (June 2015) Authors: Tong, Xiuzhen; Li, Juan; Zhou, Zhenhai; Zheng, Dong; Liu, Junru; Su, Chang Journal: Leukemia & lymphoma Issue: Volume 56:Issue 6(2015:Jun.) Page Start: 1911 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Histone methylation modification patterns and relevant M-RiskScore in acute myeloid leukemia. Issue 9 (September 2022) Authors: Rong, Dade; Chen, Xiaomin; Xiao, Jing; Liu, Daiyuan; Ni, Xiangna; Tong, Xiuzhen; Wang, Haihe Journal: Heliyon Issue: Volume 8:Issue 9(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Independent oncogenic and therapeutic significance of phosphatase PRL‐3 in FLT3‐ITD–negative acute myeloid leukemia. Issue 14 (15th April 2014) Authors: Qu, Shuang; Liu, Bin; Guo, Xiaoling; Shi, Hongshun; Zhou, Meifeng; Li, Li; Yang, Shulan; Tong, Xiuzhen; Wang, Haihe Journal: Cancer Issue: Volume 120:Issue 14(2014) Page Start: 2130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Independent oncogenic and therapeutic significance of phosphatase PRL‐3 in FLT3‐ITD–negative acute myeloid leukemia. Issue 14 (15th April 2014) Authors: Qu, Shuang; Liu, Bin; Guo, Xiaoling; Shi, Hongshun; Zhou, Meifeng; Li, Li; Yang, Shulan; Tong, Xiuzhen; Wang, Haihe Journal: Cancer Issue: Volume 120:Issue 14(2014) Page Start: 2130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia. Issue 4 (3rd April 2018) Authors: Xu, Limei; Zhang, Mingming; Li, Hui; Guan, Wen; Liu, Bin; Liu, Fengqi; Wang, Hehua; Li, Juan; Yang, Shulan; Tong, Xiuzhen; Wang, Haihe Journal: Leukemia & lymphoma Issue: Volume 59:Issue 4(2018) Page Start: 918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗